Qing Yin

1.9k total citations · 1 hit paper
27 papers, 1.3k citations indexed

About

Qing Yin is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Qing Yin has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Qing Yin's work include Ubiquitin and proteasome pathways (6 papers), Melanoma and MAPK Pathways (4 papers) and Cancer-related molecular mechanisms research (4 papers). Qing Yin is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Melanoma and MAPK Pathways (4 papers) and Cancer-related molecular mechanisms research (4 papers). Qing Yin collaborates with scholars based in China, United States and Hong Kong. Qing Yin's co-authors include Lixin Wan, Rahim Ullah, Jing Zhang, Shuangxi Zhang, Chen Huang, Yuping Zhang, Wei Duan, Zhi Hou, He Zhu and Chunqing Zhang and has published in prestigious journals such as Nature Communications, Blood and Biochemical and Biophysical Research Communications.

In The Last Decade

Qing Yin

25 papers receiving 1.3k citations

Hit Papers

RAF-MEK-ERK pathway in cancer evolution and treatment 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RAF-MEK-ERK pathway in cancer evolution and treatment
    2021 292 citations Rahim Ullah, Qing Yin et al. Seminars in Cancer Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Yin China 17 718 221 187 175 109 27 1.3k
Jinxia Hu China 24 853 1.2× 292 1.3× 133 0.7× 169 1.0× 70 0.6× 74 1.6k
Boxu Ren China 19 550 0.8× 146 0.7× 140 0.7× 226 1.3× 129 1.2× 33 1.3k
Yunshan Guo China 19 710 1.0× 161 0.7× 208 1.1× 248 1.4× 90 0.8× 38 1.3k
Fang Yuan China 20 534 0.7× 209 0.9× 156 0.8× 117 0.7× 98 0.9× 57 1.2k
Linlin Sun China 20 860 1.2× 214 1.0× 137 0.7× 128 0.7× 65 0.6× 53 1.4k
Le Yu China 25 932 1.3× 173 0.8× 357 1.9× 136 0.8× 98 0.9× 57 1.7k
Weijiang Zhao China 21 665 0.9× 339 1.5× 181 1.0× 113 0.6× 167 1.5× 86 1.4k
Qingqing Wang China 22 630 0.9× 197 0.9× 143 0.8× 79 0.5× 103 0.9× 46 1.1k

Countries citing papers authored by Qing Yin

Since Specialization
Citations

This map shows the geographic impact of Qing Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Yin more than expected).

Fields of papers citing papers by Qing Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Yin. The network helps show where Qing Yin may publish in the future.

Co-authorship network of co-authors of Qing Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Yin. A scholar is included among the top collaborators of Qing Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Yin. Qing Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Yin, Qing, Michelle Wang, Allen Hu, et al.. (2024). Combinatorial Therapy of CDK9 Inhibitor with CD19 CAR-T to Reciprocally Overcome Therapy Resistance and Enhance Treatment Efficacies Against Aggressive B-Cell Lymphomas. Blood. 144(Supplement 1). 6219–6219. 1 indexed citations
4.
Wang, Bin, Yao Wang, Yi Wen, et al.. (2022). Tubular-specific CDK12 knockout causes a defect in urine concentration due to premature cleavage of the slc12a1 gene. Molecular Therapy. 30(10). 3300–3312. 4 indexed citations
5.
Dai, Xiangpeng, Xiaoling Zhang, Qing Yin, et al.. (2022). Acetylation-dependent regulation of BRAF oncogenic function. Cell Reports. 38(3). 110250–110250. 13 indexed citations
6.
Rui, Ke, Yue Hong, Qiugang Zhu, et al.. (2021). Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren’s syndrome by modulating the function of myeloid-derived suppressor cells. Cellular and Molecular Immunology. 18(2). 440–451. 86 indexed citations
7.
Zhu, Li, Min Li, Min Yang, et al.. (2021). Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study. BMC Nephrology. 22(1). 183–183. 7 indexed citations
8.
Ullah, Rahim, et al.. (2021). RAF-MEK-ERK pathway in cancer evolution and treatment. Seminars in Cancer Biology. 85. 123–154. 292 indexed citations breakdown →
9.
Zhang, Shuangxi, et al.. (2020). <p>Overexpression of lncRNA NLIPMT Inhibits Colorectal Cancer Cell Migration and Invasion by Downregulating TGF-β1</p>. Cancer Management and Research. Volume 12. 6045–6052. 4 indexed citations
10.
Zhu, Bo, Li Zhu, Xia Lin, et al.. (2020). Roles of Ubiquitination and Deubiquitination in Regulating Dendritic Cell Maturation and Function. Frontiers in Immunology. 11. 586613–586613. 16 indexed citations
11.
Yin, Qing, et al.. (2020). ITCH as a potential therapeutic target in human cancers. Seminars in Cancer Biology. 67(Pt 2). 117–130. 38 indexed citations
12.
Yin, Qing, Tao Han, Bin Fang, et al.. (2019). K27-linked ubiquitination of BRAF by ITCH engages cytokine response to maintain MEK-ERK signaling. Nature Communications. 10(1). 1870–1870. 62 indexed citations
13.
Han, Tao, Shulong Jiang, Hong Zheng, et al.. (2019). Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis. Nature Communications. 10(1). 3716–3716. 25 indexed citations
14.
Wang, Jingzhe, Yunpeng Chen, Hui Wang, et al.. (2019). NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3. Journal of Autoimmunity. 102. 96–113. 74 indexed citations
15.
Han, Tao, Qing Yin, & Lixin Wan. (2018). AMPK lifts the PRC2-implemented gene repression. Molecular & Cellular Oncology. 5(3). e1441632–e1441632. 2 indexed citations
16.
Chen, Ming, Lixin Wan, Jiangwen Zhang, et al.. (2018). Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism. Nature Communications. 9(1). 159–159. 37 indexed citations
17.
Zhang, Shuangxi, et al.. (2015). Quercetin induces human colon cancer cells apoptosis by inhibiting the nuclear factor-kappa B Pathway. Pharmacognosy Magazine. 11(42). 404–404. 131 indexed citations
18.
Duan, Wei, Yuping Zhang, Zhi Hou, et al.. (2015). Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator. Molecular Neurobiology. 53(3). 1637–1647. 214 indexed citations
19.
Guo, Wei, Dahai Zheng, Jingyi Yang, et al.. (2014). Expression and Cellular Distribution of the Interleukin 2 Signaling System in Cortical Lesions From Patients With Focal Cortical Dysplasia. Journal of Neuropathology & Experimental Neurology. 73(3). 206–222. 17 indexed citations
20.
Ma, Yuxin, Qing Yin, Haiwei Xu, et al.. (2007). Involvement of over-expressed BMP4 in pentylenetetrazol kindling-induced cell proliferation in the dentate gyrus of adult rats. Biochemical and Biophysical Research Communications. 355(1). 54–60. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinxia Hu Breakdown of academic impact, for papers by Boxu Ren Breakdown of academic impact, for papers by Yunshan Guo Breakdown of academic impact, for papers by Fang Yuan Breakdown of academic impact, for papers by Linlin Sun Breakdown of academic impact, for papers by Le Yu Breakdown of academic impact, for papers by Weijiang Zhao Breakdown of academic impact, for papers by Qingqing Wang
Rankless by CCL
2026